GKCAS 2017 Allergy & Asthma Symposium

Overland Park, KS US
January 21, 2017

Didactic lectures allow the speakers to provide evidence based medical recommendations, updates and expert opinion in an efficient manner held in a one day meeting.


The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commerical Support
This activity is supported in part by independent medical education grants from Mylan Specialty L.P. and Teva

Target Audience

Practicing allergists, fellows-in-training, primary care physicians, advanced practice providers and allied healthcare providers in the field of allergy.

Learning Objectives

Upon completion of this activity, participants should be able to:
- identify ways in which a multi-disciplinary approach can improve patient management
- identify patients in which testing for possible food allergies is appropriate and which testing is best
- recommend strategies for long term food avoidance based on empiric recommendations or food testing results
- recommend strategies for long term management with regard to repeat endoscopic evaluations
- compare other modalities which may be used by gastroenterologists for long term surveillance

Additional information

GKCAS 2017 Allergy & Asthma Symposium
January 21, 2017
Overland Park, KS

Disclosure Policy 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no financial relationships to disclose must also inform the learners that no financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. 

Selina Gierer, DO
Speaker: TEVA, Mylan
Industry sponsored study: Genentech, Shire/Dyax

Jodi Shroba, APRN
Speaker/Consulting: MEDA

Ronald Simon, MD
Independent Contractor: CocaCola – Unrestricted educational grant

Glen Furuta, MD
Consulting: Enterotrack, UpToDate
Research funding: Nutricia, Morphotek, NIH

Rohit Katial, MD
Research funding: Teva, Astra Zeneca, GlaxoSmithKline
Speaker: Astra Zeneca
Advisory: Teva, Astra Zeneca, CSL Behring

The following have no financial relationships to disclose:
Mamta Reddy, MD
Nikita Raje, MD
Nguyen Tran, MD
Dana Wallace, MD


All identified conflicts of interest have been resolved.

Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
Course opens: 
Course expires: 
Event starts: 
01/21/2017 - 8:00am CST
Event ends: 
01/21/2017 - 1:00pm CST
Ritz Charles
9000 W. 137th Street
Overland Park, KS 66221
United States



Available Credit

  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
Please login or create an account to take this course.